11 research outputs found
PCV39 DOSE STATIN USE IN PATIENTS WITH DIABETES SAVE DOWNSTREAM RESOURCE UTILIZATION? A DIFFERENCE-IN DIFFERENCES ANALYSIS
Get PDFImpacts of black box warning, national coverage determination, and risk evaluation and mitigation strategies on the inpatient on-label and off-label use of erythropoiesis-stimulating agents
No full textPCV39 DOSE STATIN USE IN PATIENTS WITH DIABETES SAVE DOWNSTREAM RESOURCE UTILIZATION? A DIFFERENCE-IN DIFFERENCES ANALYSIS
No full textDU2 RACIAL DIAPARITIES AND BARRIER TO DRUG UTILIZATION IN PATIENTS WITH DIABETES IN THE UNITED STATES
No full textComparison of Resource use and Health Care Costs in New Initiators of Long-Acting Injectable (Lai) and Oral Second Generation Antipsychotics
No full text
The impact of copay assistance on patient out-of-pocket costs and treatment rates with ALK inhibitors
No full text
